LeonaBio (LONA) Receivables - Other (2019 - 2024)

LeonaBio (LONA) has 6 years of Receivables - Other data on file, last reported at $1.6 million in Q3 2024.

• Quarterly Receivables - Other changed N/A year-over-year to $1.6 million in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $1.6 million (changed N/A YoY) and the FY2023 annual result came in at $1.6 million, up 32.68% from the prior year.
• Receivables - Other was little changed at $1.6 million in Q3 2024 per LONA's latest filing, from $1.6 million in the prior quarter.
• Across five years, Receivables - Other topped out at $2.9 million in Q1 2021 and bottomed at $1.2 million in Q4 2022.
• The 5-year median for Receivables - Other is $1.7 million (2022), against an average of $1.9 million.
• The widest annual swing landed in 2020, when Receivables - Other soared 18471.43%; it then plunged 47.47% in 2022.
• Tracing LONA's Receivables - Other over 5 years: stood at $1.3 million in 2020, then jumped by 79.69% to $2.3 million in 2021, then plunged by 47.47% to $1.2 million in 2022, then surged by 32.68% to $1.6 million in 2023, then changed by 0.0% to $1.6 million in 2024.
• Per Business Quant, the three latest LONA Receivables - Other figures stand at $1.6 million (Q3 2024), $1.6 million (Q2 2024), and $1.6 million (Q1 2024).

Peer Comparison